* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download DIR 131 - Questions and Answers on licence decision
Survey
Document related concepts
Genome (book) wikipedia , lookup
Gene therapy of the human retina wikipedia , lookup
Gene therapy wikipedia , lookup
Gene expression profiling wikipedia , lookup
Site-specific recombinase technology wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Microevolution wikipedia , lookup
Designer baby wikipedia , lookup
Genetically modified crops wikipedia , lookup
Genetic engineering wikipedia , lookup
Genetically modified food wikipedia , lookup
History of genetic engineering wikipedia , lookup
Genetically modified organism containment and escape wikipedia , lookup
Transcript
Office of the Gene Technology Regulator February 2015 Questions & Answers on licence DIR 131 – Field trial of genetically modified (GM) safflower What does this licence allow? The Commonwealth Scientific and Industrial Research Organisation (CSIRO) has received approval to trial, under limited and controlled conditions, safflower plants that have been genetically modified to alter the oil composition in the seed. The field trial may take place between February 2015 and August 2019 at up to 60 sites in Queensland, Victoria, New South Wales, ACT and Western Australia. The maximum cumulative planting area of the trial is 850 hectares over the 4 seasons. What is the purpose of the trial? The primary purpose of the field trial is to evaluate the oil content and agronomic performance of GM safflower under field conditions in various regions around Australia, and provide enough extracted oil for product development and testing in industrial processes. The GM safflower is not permitted for use in human food or animal feed. How has the GM safflower been modified? The GM safflower has been modified to alter the oil profile in the seed, specifically to increase the level of oleic acid and decrease the levels of other fatty acids. Oleic acid comprises 90-95% of the fatty acid of the GM safflower, compared to up to 80% oleic acid in non-GM safflower. The increased oleic acid was achieved by suppressing the expression of three endogenous safflower genes involved in oil production. High purity oleic acid has potential application as a raw material for industrial applications. In addition, the GM safflower contains an introduced selectable marker gene derived from a common gut bacterium, and in some cases a second marker gene derived from a jellyfish. These genes were used to identify genetically modified plant cells and plants during initial development of the GM plants in the laboratory. What controls have been imposed for this release? The Risk Assessment and Risk Management Plan (RARMP) for this application concludes that the proposed release poses negligible risks to people or the environment. However, a range of licence conditions will limit the size, locations and duration of the release, as well as restrict the spread and persistence of the GM safflower and the introduced genetic material. Control measures include conditions that require containment of plants at the trial sites, secure transport and storage of the GM plant materials, and post-harvest monitoring at the trial site to ensure all GM safflower plants are destroyed. Want more information? A number of documents relating to this decision are available on the DIR 131 page of the OGTR website or via Freecall 1800 181 030. These documents include the finalised RARMP, a summary of the RARMP and the licence. The Office of the Gene Technology Regulator Tel: 1800 181 030 E-mail: [email protected] OGTR website